Papers and Presentations
How to Search for Resources
You can search for a variety of content on the CASSS website. CASSS makes available any content with author approval. Narrow your search by using the various filters shown below, such as Resource Type, Event Type, and Year. Refine your search as needed.
Refine Results
Filter By Resource Type
Filter By Event Types
-
CMC Strategy During the Accelerated Development of Brineura (cerliponase alfa)
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/wcbp/2023/wcbp2023_120x120_landing593821b0-7ff0-444d-b8da-38a4481654c2.jpg?sfvrsn=40f36ee0_1)
Speaker Presentation Wilbur Linda BioMarin Pharmaceutical Inc. and Jacoby David BioMarin Pharmaceutical … -
Fast Test, Faster Results for Biosafety Testing: A Rapid Degenerate PCR & Fragment Analysis Sequencing Platform
Speaker Presentation Sohrabi Afshin BioReliance Corporation 2019
-
Navigating the CMC and Regulatory Challenges of a Breakthrough Therapy Product for Multiple Myeloma
Speaker Presentation Schaefer Gene Janssen R&D, LLC 2019
-
Leveraging Innovation to Improve Patient Access & Global Health
Speaker Presentation Robinson David The Bill & Melinda Gates Foundation 2019
-
Process Science to Regulatory Science: Control Strategy and Established Conditions 2019
Speaker Presentation Robbins David MedImmune, A member of the AstraZeneca Group 2019
-
Biologics in Brazil: Overview and Perspectives on Harmonization
Speaker Presentation Rama Elkiane ANVISA 2019
-
Access-by-Design:
Making Biologics Available to All
Speaker Presentation Ram Rajeev MIT and Springs Stacy MIT 2019
-
The Role of the Biological Laboratory in the Regulation of the Quality of Biological Products
Speaker Presentation Pines Gilia Israeli Ministry of Health 2019
-
African Medicines Regulatory Harmonization - AMRH: Current Trends
Speaker Presentation Owusu-Danso Patrick Food and Drug Authority, Ghana 2019
-
PMDA Updates with a Focus on GMP/CMC
Speaker Presentation Nakashima Nobu PMDA-Pharmaceuticals and Medical Devices Agency 2019
-
Performance Based Approaches an Enabler
for Process Analytical Technology (PAT)
Speaker Presentation Moore Christine Merck & Co., Inc. 2019
-
Health Canada’s Participation at ICH &Considering ICH-Q12 Implementation
Speaker Presentation Lourenco Celia Health Canada 2019
-
Mapping Future Technology Needs and Prioritization of Critical Quality Attributes for Enabling In-Line Monitoring and Real Time Release Testing
Speaker Presentation Loladze Vaho GlaxoSmithKline 2019
-
WHO Standards for Biotherapeutics: Tools for Regulatory Convergence
Speaker Presentation Knezevic Invana World Health Organization (WHO) 2019
-
Improving Patient Access & Public Health: How Global Health Authorities and Industry can Collaborate on CMC Expectations
Speaker Presentation Karikari-Boateng Eric Food and Drug Authority, Ghana 2019
-
An Advanced Process Control Framing to Application of Analytics and Modeling for Biopharm Manufacturing
Speaker Presentation Guenard Robert Biogen 2019
-
Biosimilar Regulation in Israel
Speaker Presentation BenNaim Vered Israeli Ministry of Health 2019
-
Unsupervised Machine Learning for Improved Understanding, Optimization, and Process Monitoring, Fault Diagnosis in Early Development
Speaker Presentation Afanador Nelson Merck & Co., Inc. 2019
-
Successful On-line Interfacing of MS with Traditionally Non-MS Compatible LC Methods
![System.Collections.Generic.List`1[System.String] Thumbnail](https://www.casss.org/images/default-source/mass-spec/ms2022_120x120_landing.jpg?sfvrsn=80296e8c_3)
Roundtable 15 Notes: Mass Spec 2019 -
Software Analysis of MS Data - Emerging Approaches and Best Practices
Roundtable 13 Notes: Mass Spec 2019